APA (7th ed.) Citation

Zapata-Arriaza, E., Medina-Rodríguez, M., Moniche Álvarez, F., de Albóniga-Chindurza, A., Aguilar-Pérez, M., Ainz-Gómez, L., . . . Mosteiro, S. (2024). Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial). Trials, 25(1), 1. https://doi.org/10.1186/s13063-023-07817-9

Chicago Style (17th ed.) Citation

Zapata-Arriaza, Elena, et al. "Statistical Analysis Plan for the Multicenter, Open, Randomized Controlled Clinical Trial to Assess the Efficacy and Safety of Intravenous Tirofiban Vs Aspirin in Acute Ischemic Stroke Due to Tandem Lesion, Undergoing Recanalization Therapy by Endovascular Treatment (ATILA Trial)." Trials 25, no. 1 (2024): 1. https://doi.org/10.1186/s13063-023-07817-9.

MLA (9th ed.) Citation

Zapata-Arriaza, Elena, et al. "Statistical Analysis Plan for the Multicenter, Open, Randomized Controlled Clinical Trial to Assess the Efficacy and Safety of Intravenous Tirofiban Vs Aspirin in Acute Ischemic Stroke Due to Tandem Lesion, Undergoing Recanalization Therapy by Endovascular Treatment (ATILA Trial)." Trials, vol. 25, no. 1, 2024, p. 1, https://doi.org/10.1186/s13063-023-07817-9.